CPD Accreditation for EPiC’s Virtual GMDP Symposium 2023

Continuing Professional Development (CPD) is becoming increasingly important for professionals in all industry sectors, regardless of their career level, job role, or responsibilities. Employers and professional bodies are placing more emphasis on the continuous learning and development of their employees and members.

EPiC Auditors has become a member of the CPD Certification Service which is recognised as the world’s leading and largest CPD accreditation service with over 25 years of experience. An application is in progress to accredit EPiC’s Virtual GMDP Symposium on 5th December 2023  to enable us to award CPD points to attendees of the event.

By being an accredited training provider, EPIC Auditors adds value to the learning experience of their symposium delegates by providing a quality framework that aligns their courses the event content with CPD standards and provides a recognised, independent verification of the learning outcomes and the CPD points awarded.

To find out more about CPD and our membership visit The CPD Certification Service (cpduk.co.uk)

EPiC CPD Membership Certificate

Agenda Announced For EPiC’s Virtual GMDP Symposium 2023 

Announcing EPiC Auditors Virtual Symposium 2023

EPiC can now reveal our full agenda for our Virtual GMDP Compliance Symposium,  Beyond the Basics: Mastering GMDP Compliance and Inspection Readiness, taking place on Tuesday 5th December 2023.

Agenda Overview:

  • Recent Updates to Guidance & Regulations
  • How do you know you are Inspection Ready?
  • Deficiency Data-Interpretation & Root Cause Analysis
  • Innovation and ATMP Panel Discussion
  • Annex 1 – Contamination Control Strategy (CCS) / Gap Assessments – Workshop
  • ICH Q9 (new revision) – Risk Assessment
  • GDP Masterclass – challenges faced by RPis, The Windsor Framework update, GDP inspection approaches
  • Q&A Panel Session

Download the full agenda here:

Please take note that our schedules are subject to changes, depending on the situation at the discretion of the organisers.


🔍Meet the Experts🔎

Our carefully selected speakers bring a wealth of industry knowledge, having served as MHRA Inspectors. Their expertise and insights will provide you with invaluable guidance in navigating the complex landscape of regulatory compliance.

Discover how our expertise can take you beyond the ‘basics’ and propel your organisation towards excellence in pharmaceutical manufacturing and compliance!

Click here to read more about our speakers!

Not available on the day? We understand your schedule may not allow you to attend all the sessions of the event. A recording of the event will remain open 24/7 for 30 days. You can access the presentations whenever it’s convenient for you during this time.

Have a question? Need to register multiple people or pay offline?

Please email enquiries@epic-auditors.co.uk

We hope to see you there!

European Forum for GCP On-line Seminar: Renovation & Regulation

The European Forum for Good Clinical Practice (EFGCP) are hosting a half day seminar this autumn on regulatory and ethical hot topics including practical considerations for ICH GCP E6(R3) Renovation, Investigational Medicinal Product (IMP) Regulations (EU and UK IMP considerations for compliance), an update from the MHRA GCP Inspectorate and ethical discussions on consent modernisation.

EPiC Auditors are pleased to support the event hosted by the Quality Working Party. Pharma compliance expert Michelle Yeomans will be delivering a presentation on the Clinical Trials Regulation transition and the implications for IMP management to ensure compliance. We believe in the importance of collaboration and knowledge exchange in the field of clinical trials to improve and protect public health.

The virtual seminar takes place on Monday, September 11th, 2023, and brings together leading experts and stakeholders to discuss practical considerations, updates, and ethical debates that are at the forefront of the industry.

To see the full agenda and register please visit the EFGCP Website.

Making Pharmaceuticals Conference

Serious about Making Pharmaceuticals?

Our Directors Richard Andrews and Darren Jones will be joining GMP Healthcare Ltd on stand 220 at this year’s Making Pharmaceuticals Conference in Coventry on the 25th – 26th April 2023.

As the largest Pharmaceutical Event in the UK, it covers everything from Processing, Medical Devices, Regulatory, Clinical Testing, Research & Development, Operational Excellence, Pharmaceutical Quality, Serialisation, Clinical Trial Testing, Ingredients / Excipients, Microbiology, Pharmaceutical Engineering, Packaging & Labelling, New Technologies & Data Management.

We will be on hand to discuss any challenges you are facing and offering our expertise to help pharmaceutical and biotechnology companies, as well as other associated healthcare clients, to achieve and maintain regulatory compliance and excellent pharmaceutical quality systems, to best industry standards.

Registrations are open for your complimentary Exhibition & Conference passes. It will be great to catch up with clients and colleagues old and new. If you are attending, please come along and say hello at the Making Pharmaceuticals Conference!

Making Pharmaceuticals Conference

WE SPECIALISE in helping pharmaceutical and biotechnology companies, as well as other associated healthcare clients, to achieve and maintain regulatory compliance and excellent pharmaceutical quality systems, to best industry standards. As ex MHRA inspectors, we know how the Regulators work and think. No consultants know how the MHRA operates better than we do.  We specialise in mock inspections; GXP audits, supply chain and system audits. We work with large organisations but also have a particular interest in supporting new and expanding small companies including wholesalers; contract laboratories and clinical development laboratories.

Autumn Compliance Seminar Speaker Updates

EPiC Auditors Autumn Compliance Seminar: Thursday 10th November 2022

Here’s what our seminar speakers have to say about the event;

“A condition of holding an MIA and WDA(H) is that the guidelines on GMP and GDP are complied with. Sustaining the required level of compliance is a must to ensure medicinal products of the right quality are manufactured and distributed and avoid regulatory action. My presentation on Future-proofing compliance will explore what licence holders can and should do to continually improve and not only fulfil but exceed this requirement.” 

Richard Andrews, EPiC Auditors Managing Director & Senior Consultant   
Seminar

With the deadline for the implementation of Annex1 fast approaching, now is a great time to consider the implications for your sterile processes.  At the EPiC Autumn Compliance Seminar, I will roadmap those areas of the new Annex 1 that may result in many future sterility assurance deficiencies – a roadmap of the hotspots. This session will complement the session from Rick Parker of the MHRA, who will provide the latest MHRA thinking on Annex 1. A great opportunity to get ahead of the Annex 1 changes!

Darren Jones, EPiC Auditors Director & Senior Consultant
Seminar

To find out more about the seminar and to book your tickets click on the link below:

What was it?

This online seminar was a full day delivered remotely comprising a variety of ex MHRA Inspector speakers with invited guest speaker Richard Parker, Senior GMDP Inspector at the MHRA who will be delivering an MHRA update on Annex 1 with a regulators view of the changes. 

Altogether was a thought-provoking and informative day which aimed to:

  • Share recent changes and updates to the GMP and GDP Guidelines and Regulations with particular focus on Annex 1.
  • Highlight changes to inspection practices and MHRA oversight.
  • Discuss tools and practices to maintain compliance.
  • Present current and future Annex 1 deficiencies, along with the pitfalls to avoid.
  • Provide insight into the changes arising from the implementation of the Clinical Trials Regulations and points to consider around the IMP / GCP Interface.
  • Explore the challenges and considerations when moving from an R & D to a GMP Environment.

This event provided updates and information on recent changes to guidelines and regulations as well insights into current deficiency trends and inspection practices.